AUTHOR=Kaboré Mikaila , Sondo Kongnimissom Apoline , Dahourou Désiré Lucien , Cissoko Yacouba , Konaté Issa , Zaré Abdoulaye , Bicaba Brice , Ouedraogo Boukary , Barro Hermann , Diendéré Eric Arnaud , Asamoah Isabella , Damoue Sandrine Nadège , Siri Baperman Abdel Aziz , Diallo Ismael , Puplampu Peter , Poda Armel G. , Toloba Yacouba , Dao Sounkalo , Ouédraogo Martial , Kouanda Seni TITLE=Incidence and Predictors of Imported Cases of COVID-19 in Burkina Faso JOURNAL=Frontiers in Public Health VOLUME=10 YEAR=2022 URL=https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2022.743248 DOI=10.3389/fpubh.2022.743248 ISSN=2296-2565 ABSTRACT=Background

To limit the spread of COVID-19 due to imported cases, Burkina Faso has set up quarantine measures for arriving passengers. We aimed to determine the incidence and predictors of imported cases of COVID-19 in Burkina Faso.

Methods

A prospective cohort study was performed using data from passengers arriving at the airport from April 9 to August 31, 2020. The data was extracted from the District Health Information Software 2 (DHIS2) platform. Cox regression was used to identify predictors of imported cases of COVID-19.

Results

Among 6,332 travelers who arrived in the study period, 173 imported cases (2.7%) were recorded. The incidence rate was 1.9 cases per 1,000 traveler-days (95%CI: 1.6–2.2 per 1,000). Passengers arriving in April (Adjusted hazard ratio [aHR] = 3.56; 95%CI: 1.62–7.81) and May (aHR = 1.92; 95% CI: 1.18–3.12) were more at risk of being tested positive compared to those arriving in August, as well as, passengers presenting with one symptom (aHR = 3.71; 95% CI: 1.63–8.43) and at least two symptoms (aHR = 10.82; 95% CI: 5.24–22,30) compared to asymptomatic travelers.

Conclusions

The incidence of imported cases was relatively low in Burkina Faso between April and August 2020. The period of travel and the presence of symptoms at arrival predicted the risk of being tested positive to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This is essential in the context of the high circulation of virus variants worldwide and the low local capacity to perform genotyping tests to strengthen the surveillance and screening capacities at the points of entry into the country.